<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Genetic Technologies Ltd

    Genetic Technologies Ltd

    Genetic Technologies is a leader in the development of genetic technology. Our tes...

    Genetic Technologies is a leader in the develop...

    Filing Type:    PU
    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...

    Oncternal Therapeutics is a clinical-stage onco...

    Filing Type:    PU
    Terumo Corp.

    Terumo Corp.

    Terumo Corporation is a manufacturer and supplier of pharmaceuticals and medical t...

    Terumo Corporation is a manufacturer and suppli...

    Filing Type:    PU
    INMODE LTD.

    INMODE LTD.

    InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical tech...

    InMode Ltd. (Nasdaq: INMD) is a leading global ...

    Filing Type:    PU
    Myriad Genetics, Inc.

    Myriad Genetics, Inc.

    Myriad Genetics, Inc., is a leading precision medicine company dedicated to being ...

    Myriad Genetics, Inc., is a leading precision m...

    Filing Type:    PU
    Guardant Health, Inc.

    Guardant Health, Inc.

    We are a leading precision oncology company focused on helping conquer cancer glob...

    We are a leading precision oncology company foc...

    Filing Type:    PU
    Vaccinex, Inc.

    Vaccinex, Inc.

    Vaccinex is a clinical-stage biotechnology company engaged in the discovery and de...

    Vaccinex is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Cytosorbents Corporation

    Cytosorbents Corporation

    CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care immun...

    CytoSorbents Corporation (NASDAQ: CTSO) is a Ne...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    Principia Biopharma Inc.

    Principia Biopharma Inc.

    We are a late-stage biopharmaceutical company dedicated to bringing transformative...

    We are a late-stage biopharmaceutical company d...

    Filing Type:    PU
    ArQule, Inc.

    ArQule, Inc.

    ArQule is a biopharmaceutical company engaged in the research and development of t...

    ArQule is a biopharmaceutical company engaged i...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.